Copyright Reports & Markets. All rights reserved.

Global Dose Assessment Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Dose Assessment by Type
    • 1.3.1 Overview: Global Dose Assessment Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Dose Assessment Consumption Value Market Share by Type in 2025
    • 1.3.3 Dosimeters
    • 1.3.4 Area Process Monitors
  • 1.4 Global Dose Assessment Market by Application
    • 1.4.1 Overview: Global Dose Assessment Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Radiography
    • 1.4.3 Angiography
    • 1.4.4 Mammography
    • 1.4.5 Fluoroscopy and Interventional Imaging
    • 1.4.6 Others
  • 1.5 Global Dose Assessment Market Size & Forecast
  • 1.6 Global Dose Assessment Market Size and Forecast by Region
    • 1.6.1 Global Dose Assessment Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Dose Assessment Market Size by Region, (2021-2032)
    • 1.6.3 North America Dose Assessment Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Dose Assessment Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Dose Assessment Market Size and Prospect (2021-2032)
    • 1.6.6 South America Dose Assessment Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Dose Assessment Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Bayer AG
    • 2.1.1 Bayer AG Details
    • 2.1.2 Bayer AG Major Business
    • 2.1.3 Bayer AG Dose Assessment Product and Solutions
    • 2.1.4 Bayer AG Dose Assessment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Bayer AG Recent Developments and Future Plans
  • 2.2 GE Healthcare
    • 2.2.1 GE Healthcare Details
    • 2.2.2 GE Healthcare Major Business
    • 2.2.3 GE Healthcare Dose Assessment Product and Solutions
    • 2.2.4 GE Healthcare Dose Assessment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 GE Healthcare Recent Developments and Future Plans
  • 2.3 INFINITT Healthcare
    • 2.3.1 INFINITT Healthcare Details
    • 2.3.2 INFINITT Healthcare Major Business
    • 2.3.3 INFINITT Healthcare Dose Assessment Product and Solutions
    • 2.3.4 INFINITT Healthcare Dose Assessment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 INFINITT Healthcare Recent Developments and Future Plans
  • 2.4 Landauer Inc
    • 2.4.1 Landauer Inc Details
    • 2.4.2 Landauer Inc Major Business
    • 2.4.3 Landauer Inc Dose Assessment Product and Solutions
    • 2.4.4 Landauer Inc Dose Assessment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Landauer Inc Recent Developments and Future Plans
  • 2.5 Medic Vision Imaging Solutions
    • 2.5.1 Medic Vision Imaging Solutions Details
    • 2.5.2 Medic Vision Imaging Solutions Major Business
    • 2.5.3 Medic Vision Imaging Solutions Dose Assessment Product and Solutions
    • 2.5.4 Medic Vision Imaging Solutions Dose Assessment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Medic Vision Imaging Solutions Recent Developments and Future Plans
  • 2.6 Mirion Technologies
    • 2.6.1 Mirion Technologies Details
    • 2.6.2 Mirion Technologies Major Business
    • 2.6.3 Mirion Technologies Dose Assessment Product and Solutions
    • 2.6.4 Mirion Technologies Dose Assessment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Mirion Technologies Recent Developments and Future Plans
  • 2.7 Novarad Corporation
    • 2.7.1 Novarad Corporation Details
    • 2.7.2 Novarad Corporation Major Business
    • 2.7.3 Novarad Corporation Dose Assessment Product and Solutions
    • 2.7.4 Novarad Corporation Dose Assessment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Novarad Corporation Recent Developments and Future Plans
  • 2.8 Philips Healthcare
    • 2.8.1 Philips Healthcare Details
    • 2.8.2 Philips Healthcare Major Business
    • 2.8.3 Philips Healthcare Dose Assessment Product and Solutions
    • 2.8.4 Philips Healthcare Dose Assessment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Philips Healthcare Recent Developments and Future Plans
  • 2.9 Sectra
    • 2.9.1 Sectra Details
    • 2.9.2 Sectra Major Business
    • 2.9.3 Sectra Dose Assessment Product and Solutions
    • 2.9.4 Sectra Dose Assessment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Sectra Recent Developments and Future Plans
  • 2.10 Thermo Fisher Scientific Inc
    • 2.10.1 Thermo Fisher Scientific Inc Details
    • 2.10.2 Thermo Fisher Scientific Inc Major Business
    • 2.10.3 Thermo Fisher Scientific Inc Dose Assessment Product and Solutions
    • 2.10.4 Thermo Fisher Scientific Inc Dose Assessment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Thermo Fisher Scientific Inc Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Dose Assessment Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Dose Assessment by Company Revenue
    • 3.2.2 Top 3 Dose Assessment Players Market Share in 2025
    • 3.2.3 Top 6 Dose Assessment Players Market Share in 2025
  • 3.3 Dose Assessment Market: Overall Company Footprint Analysis
    • 3.3.1 Dose Assessment Market: Region Footprint
    • 3.3.2 Dose Assessment Market: Company Product Type Footprint
    • 3.3.3 Dose Assessment Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Dose Assessment Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Dose Assessment Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Dose Assessment Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Dose Assessment Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Dose Assessment Consumption Value by Type (2021-2032)
  • 6.2 North America Dose Assessment Market Size by Application (2021-2032)
  • 6.3 North America Dose Assessment Market Size by Country
    • 6.3.1 North America Dose Assessment Consumption Value by Country (2021-2032)
    • 6.3.2 United States Dose Assessment Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Dose Assessment Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Dose Assessment Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Dose Assessment Consumption Value by Type (2021-2032)
  • 7.2 Europe Dose Assessment Consumption Value by Application (2021-2032)
  • 7.3 Europe Dose Assessment Market Size by Country
    • 7.3.1 Europe Dose Assessment Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Dose Assessment Market Size and Forecast (2021-2032)
    • 7.3.3 France Dose Assessment Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Dose Assessment Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Dose Assessment Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Dose Assessment Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Dose Assessment Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Dose Assessment Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Dose Assessment Market Size by Region
    • 8.3.1 Asia-Pacific Dose Assessment Consumption Value by Region (2021-2032)
    • 8.3.2 China Dose Assessment Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Dose Assessment Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Dose Assessment Market Size and Forecast (2021-2032)
    • 8.3.5 India Dose Assessment Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Dose Assessment Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Dose Assessment Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Dose Assessment Consumption Value by Type (2021-2032)
  • 9.2 South America Dose Assessment Consumption Value by Application (2021-2032)
  • 9.3 South America Dose Assessment Market Size by Country
    • 9.3.1 South America Dose Assessment Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Dose Assessment Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Dose Assessment Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Dose Assessment Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Dose Assessment Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Dose Assessment Market Size by Country
    • 10.3.1 Middle East & Africa Dose Assessment Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Dose Assessment Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Dose Assessment Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Dose Assessment Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Dose Assessment Market Drivers
  • 11.2 Dose Assessment Market Restraints
  • 11.3 Dose Assessment Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Dose Assessment Industry Chain
  • 12.2 Dose Assessment Upstream Analysis
  • 12.3 Dose Assessment Midstream Analysis
  • 12.4 Dose Assessment Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Dose Assessment market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    Dose Assessment is the assessment of absorbed doses to organs and tissues of the body to evaluate possible biological effects.
    This report is a detailed and comprehensive analysis for global Dose Assessment market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Dose Assessment market size and forecasts, in consumption value ($ Million), 2021-2032
    Global Dose Assessment market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global Dose Assessment market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global Dose Assessment market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Dose Assessment
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Dose Assessment market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bayer AG, GE Healthcare, INFINITT Healthcare, Landauer Inc, Medic Vision Imaging Solutions, Mirion Technologies, Novarad Corporation, Philips Healthcare, Sectra, Thermo Fisher Scientific Inc, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Dose Assessment market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Dosimeters
    Area Process Monitors
    Market segment by Application
    Radiography
    Angiography
    Mammography
    Fluoroscopy and Interventional Imaging
    Others
    Market segment by players, this report covers
    Bayer AG
    GE Healthcare
    INFINITT Healthcare
    Landauer Inc
    Medic Vision Imaging Solutions
    Mirion Technologies
    Novarad Corporation
    Philips Healthcare
    Sectra
    Thermo Fisher Scientific Inc
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Dose Assessment product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Dose Assessment, with revenue, gross margin, and global market share of Dose Assessment from 2021 to 2026.
    Chapter 3, the Dose Assessment competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Dose Assessment market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Dose Assessment.
    Chapter 13, to describe Dose Assessment research findings and conclusion.

    Buy now